cdmo.directory
← Compare landing

Eurofins Central Laboratory vs HitGen Inc.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/eurofins/hitgen

CategoryEurofins Central LaboratoryHitGen Inc.
Listed sitebothboth
SummaryGlobal network of over 950 laboratories across 57 countries offering comprehensive contract research, testing, and manufacturing services including BioPharma discovery, bioanalysis, Phase I clinics, CDMO, central laboratory services, and specialized analytical testing.HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.
Services
  • Central Laboratory Services
  • Phase I Clinical Trials
  • Bioanalysis
  • Genomics & Sequencing Services
  • Translational Research
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Discovery Research
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Oligonucleotide Manufacturing
  • Bioinformatics & Data Science
  • Bioanalysis
  • Analytical Method Development & Validation
  • Preclinical In Vitro Studies
  • Genomics & Sequencing Services
ModalitiesData not yet provided.
  • Small Molecule
  • Oligonucleotide
  • Peptide
IndicationsData not yet provided.
  • Oncology
  • Immunology
  • Ophthalmology
  • Infectious Disease
  • Metabolic
  • Cardiovascular
Locations
  • Headquarters
  • Houston, Houston, United States
  • Headquarters, Chengdu, China
  • Cambridge, Cambridge, United Kingdom
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.